| Title: |
Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer ; The VIABLE Phase 3 Randomized Clinical Trial |
| Authors: |
Vogelzang, Nicholas J.; Beer, Tomasz M.; Gerritsen, Winald; Oudard, Stéphane; Wiechno, Pawel; Kukielka-Budny, Bozena; Samal, Vladimir; Hajek, Jaroslav; Feyerabend, Susan; Khoo, Vincent; Stenzl, Arnulf; Csöszi, Tibor; Filipovic, Zoran; Goncalves, Frederico; Prokhorov, Alexander; Cheung, Eric; Hussain, Arif; Sousa, Nuno; Bahl, Amit; Hussain, Syed; Fricke, Harald; Kadlecova, Pavla; Scheiner, Tomas; Korolkiewicz, Roman P.; Bartunkova, Jirina; Spisek, Radek; Stadler, Walter; Berg, Arthur S.; Kurth, Karl-Heinz; Higano, Celestia S.; Aapro, Matti; Krainer, Michael; Hruby, Stephan; Meran, Johannes; Polyakov, Sergey; Machiels, Jean-Pascal; Roumeguere, Thierry; Ackaert, Koen; Lumen, Nicolaas; Gil, Thierry; Minchev, Velko; Tomova, Antoaneta; Dimitrov, Borislav; Koleva, Marchela; Juretic, Antonio; Fröbe, Ana; Vojnovic, Zeljko; Drabek, Martin; Jarolim, Ladislav; Buchler, Tomas |
| Source: |
JAMA Oncology ; volume 8, issue 4, page 546 ; ISSN 2374-2437 |
| Publisher Information: |
American Medical Association (AMA) |
| Publication Year: |
2022 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1001/jamaoncol.2021.7298 |
| Availability: |
https://doi.org/10.1001/jamaoncol.2021.7298; https://jamanetwork.com/journals/jamaoncology/articlepdf/2789073/jamaoncology_vogelzang_2022_oi_210103_1650482101.5322.pdf |
| Accession Number: |
edsbas.F679F51A |
| Database: |
BASE |